Alpha 2.0

» Articles » PMID: 33593073

MiR-33 Silencing Reprograms the Immune Cell Landscape in Atherosclerotic Plaques

Overview

Overview

Journal Circ Res

Specialty Cardiology & Vascular Diseases

Date 2021 Feb 17

PMID 33593073

Citations 25

Authors

Authors

Milessa Silva Afonso

Monika Sharma

Martin Schlegel

Coen van Solingen

Graeme J Koelwyn

Lianne C Shanley

Lauren Beckett

Daniel Peled

Karishma Rahman

Chiara Giannarelli

Huilin Li

Emily J Brown

Alireza Khodadadi-Jamayran

Edward A Fisher

Kathryn J Moore

Affiliations

Affiliations

Soon will be listed here.

Abstract

[Figure: see text].

Citing Articles

Immune checkpoint landscape of human atherosclerosis and influence of cardiometabolic factors.

Barcia Duran J, Das D, Gildea M, Amadori L, Gourvest M, Kaur R Nat Cardiovasc Res. 2024; 3(12):1482-1502.

PMID: 39613875 PMC: 11634783. DOI: 10.1038/s44161-024-00563-4.

Targeting Unc5b in macrophages drives atherosclerosis regression and pro-resolving immune cell function.

Schlegel M, Cyr Y, Newman A, Schreyer K, Barcia Duran J, Sharma M Proc Natl Acad Sci U S A. 2024; 121(44):e2412690121.

PMID: 39436659 PMC: 11536151. DOI: 10.1073/pnas.2412690121.

The ability of microRNAs to regulate the immune response in ischemia/reperfusion inflammatory pathways.

Artimovic P, Spakova I, Macejkova E, Pribulova T, Rabajdova M, Marekova M Genes Immun. 2024; 25(4):277-296.

PMID: 38909168 PMC: 11327111. DOI: 10.1038/s41435-024-00283-6.

Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets.

Chen R, Zhang H, Tang B, Luo Y, Yang Y, Zhong X Signal Transduct Target Ther. 2024; 9(1):130.

PMID: 38816371 PMC: 11139930. DOI: 10.1038/s41392-024-01840-1.

miR-369-3p ameliorates diabetes-associated atherosclerosis by regulating macrophage succinate-GPR91 signalling.

Rawal S, Randhawa V, Rizvi S, Sachan M, Wara A, Perez-Cremades D Cardiovasc Res. 2024; 120(14):1693-1712.

PMID: 38703377 PMC: 11587565. DOI: 10.1093/cvr/cvae102.

References

1.

Proto J, Doran A, Gusarova G, Yurdagul Jr A, Sozen E, Subramanian M . Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution. Immunity. 2018; 49(4):666-677.e6. PMC: 6192849. DOI: 10.1016/j.immuni.2018.07.015. View

2.

Boshuizen M, de Winther M . Interferons as Essential Modulators of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2015; 35(7):1579-88. DOI: 10.1161/ATVBAHA.115.305464. View

3.

Fernandez D, Rahman A, Fernandez N, Chudnovskiy A, Amir E, Amadori L . Single-cell immune landscape of human atherosclerotic plaques. Nat Med. 2019; 25(10):1576-1588. PMC: 7318784. DOI: 10.1038/s41591-019-0590-4. View

4.

Feig J, Vengrenyuk Y, Reiser V, Wu C, Statnikov A, Aliferis C . Regression of atherosclerosis is characterized by broad changes in the plaque macrophage transcriptome. PLoS One. 2012; 7(6):e39790. PMC: 3384622. DOI: 10.1371/journal.pone.0039790. View

5.

Michalek R, Gerriets V, Jacobs S, Macintyre A, MacIver N, Mason E . Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J Immunol. 2011; 186(6):3299-303. PMC: 3198034. DOI: 10.4049/jimmunol.1003613. View

6.

Distel E, Barrett T, Chung K, Girgis N, Parathath S, Essau C . miR33 inhibition overcomes deleterious effects of diabetes mellitus on atherosclerosis plaque regression in mice. Circ Res. 2014; 115(9):759-69. PMC: 4194153. DOI: 10.1161/CIRCRESAHA.115.304164. View

7.

Kwan A, Aronis K, Sandfort V, Blumenthal R, Bluemke D . Bridging the gap for lipid lowering therapy: plaque regression, coronary computed tomographic angiography, and imaging-guided personalized medicine. Expert Rev Cardiovasc Ther. 2017; 15(7):547-558. PMC: 8286171. DOI: 10.1080/14779072.2017.1348228. View

8.

Afonso M, Verma N, van Solingen C, Cyr Y, Sharma M, Perie L . MicroRNA-33 Inhibits Adaptive Thermogenesis and Adipose Tissue Beiging. Arterioscler Thromb Vasc Biol. 2021; 41(4):1360-1373. PMC: 8011606. DOI: 10.1161/ATVBAHA.120.315798. View

9.

Dutta P, Hoyer F, Sun Y, Iwamoto Y, Tricot B, Weissleder R . E-Selectin Inhibition Mitigates Splenic HSC Activation and Myelopoiesis in Hypercholesterolemic Mice With Myocardial Infarction. Arterioscler Thromb Vasc Biol. 2016; 36(9):1802-8. PMC: 5001901. DOI: 10.1161/ATVBAHA.116.307519. View

10.

Hewing B, Parathath S, Mai C, Fiel M, Guo L, Fisher E . Rapid regression of atherosclerosis with MTP inhibitor treatment. Atherosclerosis. 2013; 227(1):125-9. PMC: 4047651. DOI: 10.1016/j.atherosclerosis.2012.12.026. View

11.

Ouimet M, Ediriweera H, Afonso M, Ramkhelawon B, Singaravelu R, Liao X . microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis. Arterioscler Thromb Vasc Biol. 2017; 37(6):1058-1067. PMC: 5494696. DOI: 10.1161/ATVBAHA.116.308916. View

12.

Mueller P, Zhu L, Tavori H, Huynh K, Giunzioni I, Stafford J . Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque Macrophages. Circulation. 2018; 138(17):1850-1863. PMC: 6343494. DOI: 10.1161/CIRCULATIONAHA.117.031702. View

13.

Aran D, Looney A, Liu L, Wu E, Fong V, Hsu A . Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol. 2019; 20(2):163-172. PMC: 6340744. DOI: 10.1038/s41590-018-0276-y. View

14.

Kyaw T, Winship A, Tay C, Kanellakis P, Hosseini H, Cao A . Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in apoE-deficient mice. Circulation. 2013; 127(9):1028-39. DOI: 10.1161/CIRCULATIONAHA.112.001347. View

15.

Ait-Oufella H, Kinugawa K, Zoll J, Simon T, Boddaert J, Heeneman S . Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice. Circulation. 2007; 115(16):2168-77. DOI: 10.1161/CIRCULATIONAHA.106.662080. View

16.

Sharma M, Schlegel M, Afonso M, Brown E, Rahman K, Weinstock A . Regulatory T Cells License Macrophage Pro-Resolving Functions During Atherosclerosis Regression. Circ Res. 2020; 127(3):335-353. PMC: 7367765. DOI: 10.1161/CIRCRESAHA.119.316461. View

17.

Hemdahl A, Gabrielsen A, Zhu C, Eriksson P, Hedin U, Kastrup J . Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler Thromb Vasc Biol. 2005; 26(1):136-42. DOI: 10.1161/01.ATV.0000193567.88685.f4. View

18.

Rayner K, Esau C, Hussain F, McDaniel A, Marshall S, van Gils J . Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature. 2011; 478(7369):404-7. PMC: 3235584. DOI: 10.1038/nature10486. View

19.

Davalos A, Goedeke L, Smibert P, Ramirez C, Warrier N, Andreo U . miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc Natl Acad Sci U S A. 2011; 108(22):9232-7. PMC: 3107310. DOI: 10.1073/pnas.1102281108. View

20.

Maganto-Garcia E, Tarrio M, Grabie N, Bu D, Lichtman A . Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia. Circulation. 2011; 124(2):185-95. PMC: 3145407. DOI: 10.1161/CIRCULATIONAHA.110.006411. View